Société Peregrine Pharmaceuticals Nasdaq
Actions
US7136613046
Produits pharmaceutiques
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Mammalian Cell Culture
84,0
%
| 99 | 83,0 % | 125 | 84,0 % | +26,32% |
Process Development
16,0
%
| 20 | 17,0 % | 24 | 16,0 % | +17,40% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 120 | 100,0 % | 149 | 100,0 % | +24,81% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/07/20 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 01/08/18 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/99 |
Richard Richieri
COO | Chief Operating Officer | 59 | 09/10/19 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/11/17 |
Oksana Lukash
HRO | Human Resources Officer | - | 16/11/22 |
Michael Alston
PRN | Corporate Officer/Principal | - | 01/01/19 |
Michael Faughnan
PRN | Corporate Officer/Principal | - | - |
Elie Hanania
PRN | Corporate Officer/Principal | - | 04/11/21 |
Corporate Officer/Principal | - | 07/10/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 27/11/17 |
Joseph Carleone
CHM | Chairman | 78 | 27/11/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 25/07/19 |
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/07/20 |
Esther Alegria
BRD | Director/Board Member | 66 | 28/06/21 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 03/12/20 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/11/17 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 63 479 794 | 62 781 178 ( 98,90 %) | 0 | 98,90 % |
Coordonnées société
Secteur
Ventes par activité
Varia. 1 janv. | Capi. | |
---|---|---|
-3,74% | 88,14 Md | |
+1,45% | 40,51 Md | |
-15,94% | 31,67 Md | |
+52,66% | 24,62 Md | |
-14,50% | 15,65 Md | |
-14,38% | 12,07 Md | |
-9,12% | 11,97 Md | |
-42,56% | 11,61 Md | |
+4,87% | 8,81 Md |